Randall K. Johnson

10.0k total citations · 1 hit paper
142 papers, 8.2k citations indexed

About

Randall K. Johnson is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Randall K. Johnson has authored 142 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 42 papers in Oncology and 37 papers in Organic Chemistry. Recurrent topics in Randall K. Johnson's work include Cancer therapeutics and mechanisms (24 papers), Marine Sponges and Natural Products (22 papers) and Biochemical and Molecular Research (9 papers). Randall K. Johnson is often cited by papers focused on Cancer therapeutics and mechanisms (24 papers), Marine Sponges and Natural Products (22 papers) and Biochemical and Molecular Research (9 papers). Randall K. Johnson collaborates with scholars based in United States, United Kingdom and Netherlands. Randall K. Johnson's co-authors include Leo F. Faucette, Michael R. Mattern, Makoto Inaba, Christopher K. Mirabelli, Francis L. McCabe, Stanley T. Crooke, Robert Cafferkey, Ashok D. Patil, Alan J. Freyer and Yoshio Sakurai and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Randall K. Johnson

141 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

1979 410 citations Randall K. Johnson et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randall K. Johnson United States	48	4.7k	3.2k	2.1k	693	546	142	8.2k
Peter P. Roller United States	56	7.0k 1.5×	1.7k 0.5×	2.5k 1.2×	409 0.6×	374 0.7×	183	10.4k
Michael C. Alley United States	28	2.6k 0.5×	1.3k 0.4×	1.3k 0.6×	643 0.9×	307 0.6×	48	5.2k
Michael R. Mattern United States	46	5.8k 1.2×	2.6k 0.8×	758 0.4×	326 0.5×	653 1.2×	107	7.0k
John S. Lazo United States	61	7.9k 1.7×	2.9k 0.9×	1.5k 0.7×	654 0.9×	662 1.2×	323	13.5k
Takao Yamori Japan	57	7.7k 1.6×	2.4k 0.8×	1.9k 0.9×	1.0k 1.5×	286 0.5×	241	11.7k
Andrew T. McPhail United States	41	3.6k 0.8×	2.3k 0.7×	4.9k 2.3×	1.5k 2.2×	262 0.5×	410	10.4k
Billy W. Day United States	52	3.5k 0.7×	1.4k 0.4×	2.4k 1.2×	753 1.1×	200 0.4×	178	7.5k
Alan C. Sartorelli United States	59	8.5k 1.8×	4.9k 1.5×	3.1k 1.5×	478 0.7×	1.3k 2.3×	514	15.9k
Bruce C. Baguley New Zealand	64	9.1k 1.9×	4.3k 1.4×	3.8k 1.8×	803 1.2×	1.1k 2.0×	384	15.0k
Melinda G. Hollingshead United States	45	3.9k 0.8×	1.9k 0.6×	1.1k 0.5×	385 0.6×	277 0.5×	167	6.9k

Countries citing papers authored by Randall K. Johnson

Since Specialization

Citations

This map shows the geographic impact of Randall K. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall K. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall K. Johnson more than expected).

Fields of papers citing papers by Randall K. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall K. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall K. Johnson. The network helps show where Randall K. Johnson may publish in the future.

Co-authorship network of co-authors of Randall K. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Randall K. Johnson. A scholar is included among the top collaborators of Randall K. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall K. Johnson. Randall K. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Randall K.. (2016). How the United States Postal Service (USPS) Could Encourage More Local Economic Development. Chicago-Kent law review. 92(2). 593. 1 indexed citations

Johnson, Randall K.. (2014). Where Schools Close in Chicago. SSRN Electronic Journal. 1 indexed citations

Hoch, Ute, et al.. (2014). Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models. Cancer Chemotherapy and Pharmacology. 74(6). 1125–1137. 45 indexed citations

Iyer, Vijay, Ross Garberich, Jay H. Traverse, et al.. (2014). Ranolazine Refractory Angina Registry. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 13(3). 96–98. 7 indexed citations

Henry, Timothy D., Daniel Satran, James S. Hodges, et al.. (2013). Long-term survival in patients with refractory angina. European Heart Journal. 34(34). 2683–2688. 120 indexed citations

Johnson, Randall K.. (2012). Do Police Learn from Lawsuit Data. SSRN Electronic Journal. 1 indexed citations

Zhou, Bing‐Nan, Carla Slebodnick, Randall K. Johnson, Michael R. Mattern, & David G. I. Kingston. (2000). New Cytotoxic Manzamine Alkaloids from a Palaun Sponge. Tetrahedron. 56(32). 5781–5784. 20 indexed citations

Chaturvedi, Priya, Yuan Zhu, Michael R. Mattern, et al.. (1999). Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene. 18(28). 4047–4054. 345 indexed citations

Houghton, Peter J., et al.. (1997). Probenecid alters topotecan (TPT) systemic and renal disposition. Clinical Pharmacology & Therapeutics. 61(2). 1 indexed citations

10.

Patil, Ashok D., et al.. (1997). Piperpense, a Tetrahydropyridine Alkaloid fromPiper PonapenseStems and Leaves. Natural product letters. 9(3). 217–223. 1 indexed citations

11.

Cafferkey, Robert, Megan M. McLaughlin, Peter R. Young, Randall K. Johnson, & George P. Livi. (1994). Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. Gene. 141(1). 133–136. 44 indexed citations

12.

Eng, Wai-Kwong, Leo F. Faucette, Megan M. McLaughlin, et al.. (1994). The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. Gene. 151(1-2). 61–71. 72 indexed citations

13.

Heltzel, Carl E., A. A. Leslie Gunatilaka, David G. I. Kingston, Glenn A. Hofmann, & Randall K. Johnson. (1994). Synthesis and Structure-Activity Relationships of Cytotoxic 7-Hydroxy Sterols. Journal of Natural Products. 57(5). 620–628. 25 indexed citations

14.

Cafferkey, Robert, Peter R. Young, Megan M. McLaughlin, et al.. (1993). Dominant Missense Mutations in a Novel Yeast Protein related to Mammalian Phosphatidylinositol 3-Kinase and VPS34 Abrogate Rapamycin Cytotoxicity. Molecular and Cellular Biology. 13(10). 6012–6023. 221 indexed citations

15.

Koltin, Y., Leo F. Faucette, Derk J. Bergsma, et al.. (1991). Rapamycin Sensitivity in Saccharomyces cerevisiae Is Mediated by a Peptidyl-Prolyl cis-trans Isomerase Related to Human FK506-Binding Protein. Molecular and Cellular Biology. 11(3). 1718–1723. 188 indexed citations

16.

Berners‐Price, Susan J., Gerald R. Girard, David T. Hill, et al.. (1990). Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates. Journal of Medicinal Chemistry. 33(5). 1386–1392. 101 indexed citations

17.

Berners‐Price, Susan J., et al.. (1988). Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: Comparison with copper and gold. Journal of Inorganic Biochemistry. 33(4). 285–295. 97 indexed citations

18.

Adams, Jerry L., Thomas D. Meek, Shau Ming Mong, Randall K. Johnson, & Brian W. Metcalf. (1988). cis-4-Carboxy-6-(mercaptomethyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-one, a potent inhibitor of mammalian dihydroorotase. Journal of Medicinal Chemistry. 31(7). 1355–1359. 34 indexed citations

19.

Johnson, Randall K., Elizabeth A. Swyryd, & George R. Stark. (1978). Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase.. PubMed. 38(2). 371–8. 70 indexed citations

20.

Bogdén, Arthur E., et al.. (1978). Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(1). 59–64. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact